Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Robert J. DelucciaDirector | Acurx PharmaceuticalsACXP | Open-market buy | 25/01/06 | 25/01/08 | 49,261 sh | $1.02 | $50,246.22 | +5.1% |
David P. LuciPresident and CEO | Acurx PharmaceuticalsACXP | Open-market buy | 25/01/06 | 25/01/08 | 49,261 sh | $1.02 | $50,246.22 | +4.7% |
Joseph C. ScodariDirector | Acurx PharmaceuticalsACXP | Open-market buy | 25/01/06 | 25/01/08 | 24,631 sh | $1.02 | $25,123.62 | +800.5% |
Jack H. DeanDirector | Acurx PharmaceuticalsACXP | Open-market buy | 25/01/06 | 25/01/08 | 9,852 sh | $1.02 | $10,049.04 | +82.6% |
Carl SailerDirector | Acurx PharmaceuticalsACXP | Open-market buy | 25/01/06 | 25/01/08 | 24,631 sh | $1.02 | $25,123.62 | +21.9% |
James J. DonohueDirector | Acurx PharmaceuticalsACXP | Open-market buy | 25/01/06 | 25/01/08 | 9,852 sh | $1.02 | $10,049.04 | +78.8% |